Tumour Markers in the Diagnosis and Management of Patients with Hepatocellular Carcinoma
- 1 January 1986
- book chapter
- Published by Springer Nature
- Vol. 100, 68-72
- https://doi.org/10.1007/978-3-642-82635-1_8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- NEUROTENSIN SECRETION BY FIBROLAMELLAR CARCINOMA OF THE LIVERThe Lancet, 1984
- Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinomaBritish Journal of Cancer, 1981
- Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinomaCancer, 1981
- Electrophoretic fractionation of serum γ-glutamyl transpeptidase in human hepatic cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Alpha-Fetoprotein 3JNCI Journal of the National Cancer Institute, 1978
- Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinomaCancer, 1976
- NORMAL BIOLOGY OF α‐FETOPROTEINAnnals of the New York Academy of Sciences, 1975
- Hepatocellular Carcinoma and a Variant Alkaline PhosphataseAnnals of Internal Medicine, 1975